U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953934) titled 'A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants' on April 24.
Brief Summary: The main objective of this study is to assess the safety and tolerability of ABBV-932 in healthy adult male participants.
Study Start Date: May 12
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-932
Oral Capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....